首页|小儿消积止咳口服液联合阿奇霉素治疗小儿肺炎支原体肺炎的临床效果研究

小儿消积止咳口服液联合阿奇霉素治疗小儿肺炎支原体肺炎的临床效果研究

扫码查看
目的 探讨小儿消积止咳口服液联合阿奇霉素治疗小儿肺炎支原体肺炎的临床效果。方法 106 例小儿肺炎支原体肺炎患儿,采用随机数字表法分为对照组与观察组,每组 53 例。对照组患儿使用阿奇霉素治疗,观察组患儿在对照组基础上联合小儿消积止咳口服液治疗。比较两组患儿的中医症状积分、西医疗效、炎症因子[血清C反应蛋白(CRP)、白细胞介素-6(IL-6)和降钙素原(PCT)]及免疫功能指标[免疫球蛋白A(IgA)、免疫球蛋白G(IgG)、免疫球蛋白M(IgM)、CD4+、CD8+和CD4+/CD8+]。结果 观察组患儿服药 5 d后的咳嗽、发热和肺啰音症状积分分别为(0。54±0。19)、(0。57±0。19)、(0。75±0。23)分,均低于对照组的(1。32±0。43)、(1。63±0。34)、(1。35±0。41)分,差异有统计学意义(P<0。05)。服药 5 d后,观察组患儿的治疗总有效率 94。34%高于对照组的 77。36%,差异有统计学意义(P<0。05)。观察组患儿服药 5 d后的CRP、IL-6 和PCT水平分别为(3。65±0。62)mg/L、(5。31±0。56)pg/ml、(0。14±0。03)ng/ml,均低于对照组的(5。76±0。93)mg/L、(7。57±0。92)pg/ml、(0。31±0。09)ng/ml,差异有统计学意义(P<0。05)。观察组患儿服药 5 d后的IgA(0。76±0。08)g/L、IgM(1。13±0。34)g/L、IgG(6。75±1。32)g/L、CD8+(457。91±56。34)个/μl均低于对照组的(1。06±0。27)g/L、(1。72±0。49)g/L、(9。21±1。76)g/L、(493。59±35。76)个/μl,CD4+(1048。62±253。17)个/μl、CD4+/CD8+(2。29±0。43)均高于对照组的(824。29±147。53)个/μl、(1。67±0。29),差异有统计学意义(P<0。05)。结论 在阿奇霉素治疗小儿肺炎支原体肺炎的基础上联合使用小儿消积止咳口服液可提高治疗效果,对改善患儿症状、免疫功能,恢复正常肺功能以及减轻机体炎症反应均有积极作用,适宜临床推广使用。
Study on clinical effect of Xiao'er Xiaoji Zhike oral liquid combined with azithromycin in the treatment of Mycoplasma pneumoniae pneumonia in children
Objective To explore the clinical effect of Xiao'er Xiaoji Zhike oral liquid combined with azithromycin in the treatment of Mycoplasma pneumoniae pneumonia in children.Methods 106 child patients with Mycoplasma pneumoniae pneumonia were divided into a control group and an observation group using a random number table method,each with 53 cases.The children of the control group used azithromycin for treatment,while the children of the observation group used Xiao'er Xiaoji Zhike oral liquid combined with azithromycin for treatment.The traditional Chinese medicine symptom scores,Western medicine efficacy,inflammatory factors[serum C-reactive protein(CRP),interleukin-6(IL-6)and procalcitonin(PCT)]and immune function indicators[immunoglobulin A(IgA),immunoglobulin G(IgG),immunoglobulin M(IgM),CD4+,CD8+,and CD4+/CD8+]between the two groups of children were compared.Results After 5 d of medication,the scores of cough,fever and pulmonary rales in the observation group were(0.54±0.19),(0.57±0.19)and(0.75±0.23)points,which were lower than(1.32±0.43),(1.63±0.34)and(1.35±0.41)points in the control group.The difference was statistically significant(P<0.05).After 5 d of medication,the total effective rate of 94.34%in the observation group was higher than 77.36%in the control group,and the difference was statistically significant(P<0.05).After 5 d of medication,the levels of CRP,IL-6 and PCT in the observation group were(3.65±0.62)mg/L,(5.31±0.56)pg/ml and(0.14±0.03)ng/ml,which were lower than(5.76±0.93)mg/L,(7.57±0.92)pg/ml and(0.31±0.09)ng/ml in the control group.The difference was statistically significant(P<0.05).After 5 d of medication,the observation group had IgA of(0.76±0.08)g/L,IgM of(1.13±0.34)g/L,IgG of(6.75±1.32)g/L,and CD8+ of(457.91±56.34)/μl,which were lower than(1.06±0.27)g/L,(1.72±0.49)g/L,(9.21±1.76)g/L,and(493.59±35.76)/μl in the control group;the observation group had CD4+of(1048.62±253.17)/μl and CD4+/CD8+ of(2.29±0.43),which were higher than(824.29±147.53)/μl and(1.67±0.29)in the control group;the difference was statistically significant(P<0.05).Conclusion On the basis of azithromycin in the treatment of Mycoplasma pneumoniae pneumonia in children,the combined use of Xiao'er Xiaoji Zhike oral liquid can improve the treatment effect,and has a positive effect on improving symptoms,restoring normal lung function,and alleviating inflammatory reactions in the body.It is suitable for clinical promotion and use.

ChildrenMycoplasma pneumoniae pneumoniaXiao'er Xiaoji Zhike oral liquidAzithromycin

张颖

展开 >

272200 金乡县人民医院儿一科

小儿 肺炎支原体肺炎 小儿消积止咳口服液 阿奇霉素

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(6)
  • 20